铁洛菲班在急性中风内血管血栓切除中的第一通道再通道化:乐观的随机临床试验
Longting Lin1,2,3, Feifeng Liu1,2, Tingyu Yi4
1Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Tongji University, Shanghai, China.
JAMA network open
|April 17, 2025
概括
静脉输入的提洛菲班在内血管血栓切除术前改善了急性缺血性中风患者的结局,因为增加了第一通复通,而不会增加出血风险. 这表明tirofiban是一种有价值的手术前治疗选择.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 蒂罗菲班是一种糖蛋白IIb/IIIa受体对手,抑制了血小板聚合.
- 它在急性缺血性中风中与内血管治疗相结合的作用仍然不确定.
研究的目的:
- 评估静脉注射提洛菲班在内血管血栓切除术之前是否会改善结果.
- 具体来说,要评估它的有效性,在没有增加内出血风险的情况下实现一次通道再通道.
主要方法:
- 一个多中心,前性,随机临床试验 (NCT04851457) 涉及200名患有大血管封闭性中风的患者.
- 患者在内血管血栓切除术前接受了静脉注射蒂罗菲班或标准护理.
- 主要结局是没有症状的内出血的第一通复通.
主要成果:
- 接受提洛菲班治疗的65%的患者实现了无症状内出血的第一通复,而在标准治疗组中这一比例为48% (调整后风险比1.34).
- 症状性内出血的发病率在蒂罗菲班组为0%,对照组为6%.
- 这项研究表明,罗非班给药后,主要结果在统计学上显著改善.
结论:
- 静脉内提罗菲班在内血管血栓切除术之前给予,显著增加了成功的第一通道再通道化的可能性.
- 这种手术前的治疗没有增加症状性内出血的风险.
- 蒂罗菲班可以被认为是一种有益的抗血小板策略,以促进急性缺血性中风中的内血管血栓切除术.
相关概念视频
01:16Clot Retraction and Fibrinolysis
2.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.6K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.0K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
546
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
546